|
|
 |
|
VRTX: Vertex Pharmaceuticals Inc - Stock News |
Enter Ticker:
|
|
| Nov 23, 2009 |
BiomedReports: News and FDA Updates for Bristol-Myers (NYSE:BMY), Lannett (NYSE:LCI), Vertex (Nasdaq:VRTX) |
| Nov 20, 2009 |
Vertex Pharmaceuticals Announces Webcasts of its Presentations at Two Investor Conferences |
| Nov 17, 2009 |
Vertex Pharmaceuticals (VRTX) Downgrade Alert, Watch for 8.4% Technical Uptrend Reversal |
| Nov 17, 2009 |
Analyst Downgrades for November 17th |
| Nov 17, 2009 |
Tech stocks off the beaten path – CNNMoney |
| Nov 16, 2009 |
Vertex Pharmaceuticals (VRTX) Bullish Technical Alert - Trend Up 9.2% |
| Nov 16, 2009 |
Market Review on CMCSK, CENX, SUSQ, VRTX, CDNS and CYOU byAnalystChoice.com |
| Nov 13, 2009 |
Vertex Pharmaceuticals to Exchange Convertible Senior Subordinated Notes with Common Stock |
| Nov 12, 2009 |
Vertex Pharmaceuticals Announces Webcast of its Presentation at the Lazard Capital Markets Annual Healthcare Conference |
| Nov 11, 2009 |
BiomedReports: News and FDA Updates for Teva (Nasdaq:TEVA), Vertex (Nasdaq:VRTX) |
| Nov 10, 2009 |
Vertex Pharmaceuticals Announces Agreements to Exchange $109.0 Million of its 2013 Convertible Senior Subordinated Notes into Common Stock |
| Nov 09, 2009 |
Vertex Pharmaceuticals Up 5.9% Since SmarTrend's Buy Recommendation |
| Nov 04, 2009 |
Analyst Upgrades for November 4th |
| Nov 02, 2009 |
Dr. Stockpick Announces Daily Stock Watch - AMLN, VRTX, HGSI |
| Oct 31, 2009 |
More than 80% of Hepatitis C Patients Treated in Study C208 Achieved an SVR with Telaprevir-Based Regimens |
| |
| ZACKS COMMENTARY FOR VRTX |
|
|
|
Sponsored Links 
-0.47